BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17651449)

  • 1. Nosocomial spread of Pseudomonas aeruginosa producing the metallo-beta-lactamase VIM-2 in a Spanish hospital: clinical and epidemiological implications.
    Peña C; Suarez C; Tubau F; Gutierrez O; Domínguez A; Oliver A; Pujol M; Gudiol F; Ariza J
    Clin Microbiol Infect; 2007 Oct; 13(10):1026-9. PubMed ID: 17651449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metallo-beta-lactamase-producing Pseudomonas putida as a reservoir of multidrug resistance elements that can be transferred to successful Pseudomonas aeruginosa clones.
    Juan C; Zamorano L; Mena A; Albertí S; Pérez JL; Oliver A
    J Antimicrob Chemother; 2010 Mar; 65(3):474-8. PubMed ID: 20071364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing SPM-1 metallo-{beta}-lactamase in a teaching hospital in southern Brazil.
    Zavascki AP; Gaspareto PB; Martins AF; Gonçalves AL; Barth AL
    J Antimicrob Chemother; 2005 Dec; 56(6):1148-51. PubMed ID: 16239284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissemination of Pseudomonas aeruginosa producing SPM-1-like and IMP-1-like metallo-beta-lactamases in hospitals from southern Brazil.
    Martins AF; Zavascki AP; Gaspareto PB; Barth AL
    Infection; 2007 Dec; 35(6):457-60. PubMed ID: 18034208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metallo-beta-lactamase-producing Pseudomonas aeruginosa isolated from a large tertiary centre in Kenya.
    Pitout JD; Revathi G; Chow BL; Kabera B; Kariuki S; Nordmann P; Poirel L
    Clin Microbiol Infect; 2008 Aug; 14(8):755-9. PubMed ID: 18727799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occurrence of VIM-4 metallo-β-lactamase-producing Pseudomonas aeruginosa in an Algerian hospital.
    Merradi M; Kassah-Laouar A; Ayachi A; Heleili N; Menasria T; Hocquet D; Cholley P; Sauget M
    J Infect Dev Ctries; 2019 Apr; 13(4):284-290. PubMed ID: 32045372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial susceptibility and molecular epidemiological analysis of clinical strains of Pseudomonas aeruginosa.
    Tsuchimochi N; Takuma T; Shimono N; Nagasaki Y; Uchida Y; Harada M
    J Infect Chemother; 2008 Apr; 14(2):99-104. PubMed ID: 18622671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large dissemination of VIM-2-metallo-{beta}-lactamase-producing pseudomonas aeruginosa strains causing health care-associated community-onset infections.
    Tsakris A; Poulou A; Kristo I; Pittaras T; Spanakis N; Pournaras S; Markou F
    J Clin Microbiol; 2009 Nov; 47(11):3524-9. PubMed ID: 19776233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of a novel multidrug-resistant Pseudomonas aeruginosa strain producing IMP-type metallo-β-lactamases and AAC(6')-Iae in Japan.
    Kitao T; Tada T; Tanaka M; Narahara K; Shimojima M; Shimada K; Miyoshi-Akiyama T; Kirikae T
    Int J Antimicrob Agents; 2012 Jun; 39(6):518-21. PubMed ID: 22483560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First nosocomial outbreak of Pseudomonas aeruginosa producing an integron-borne metallo-beta-lactamase (VIM-2) in the United States.
    Lolans K; Queenan AM; Bush K; Sahud A; Quinn JP
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3538-40. PubMed ID: 16048978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First outbreak of VIM-2 metallo-β-lactamase-producing Pseudomonas aeruginosa in The Netherlands: microbiology, epidemiology and clinical outcomes.
    Van der Bij AK; Van Mansfeld R; Peirano G; Goessens WH; Severin JA; Pitout JD; Willems R; Van Westreenen M
    Int J Antimicrob Agents; 2011 Jun; 37(6):513-8. PubMed ID: 21497065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unusual diversity of acquired β-lactamases in multidrug-resistant Pseudomonas aeruginosa isolates in a Mexican hospital.
    Castillo-Vera J; Ribas-Aparicio RM; Nicolau CJ; Oliver A; Osorio-Carranza L; Aparicio-Ozores G
    Microb Drug Resist; 2012 Oct; 18(5):471-8. PubMed ID: 22554004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term evolution of a nosocomial outbreak of Pseudomonas aeruginosa producing VIM-2 metallo-enzyme.
    Corvec S; Poirel L; Espaze E; Giraudeau C; Drugeon H; Nordmann P
    J Hosp Infect; 2008 Jan; 68(1):73-82. PubMed ID: 18079018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence of a New Delhi metallo-β-lactamase-1-producing Pseudomonas aeruginosa in Singapore.
    Teo JW; La MV; Jureen R; Lin RT
    Emerg Microbes Infect; 2015 Nov; 4(11):e72. PubMed ID: 26632659
    [No Abstract]   [Full Text] [Related]  

  • 15. Nosocomial infections with metallo-beta-lactamase-producing Pseudomonas aeruginosa: molecular epidemiology, risk factors, clinical features and outcomes.
    Lucena A; Dalla Costa LM; Nogueira KS; Matos AP; Gales AC; Paganini MC; Castro ME; Raboni SM
    J Hosp Infect; 2014 Aug; 87(4):234-40. PubMed ID: 25027563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular evolution of metallo-beta-lactamase-producing Pseudomonas aeruginosa in a nosocomial setting of high-level endemicity.
    Lagatolla C; Edalucci E; Dolzani L; Riccio ML; De Luca F; Medessi E; Rossolini GM; Tonin EA
    J Clin Microbiol; 2006 Jul; 44(7):2348-53. PubMed ID: 16825348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular epidemiology of metallo-beta-lactamase-producing Pseudomonas aeruginosa in the Calgary Health Region: emergence of VIM-2-producing isolates.
    Pitout JD; Chow BL; Gregson DB; Laupland KB; Elsayed S; Church DL
    J Clin Microbiol; 2007 Feb; 45(2):294-8. PubMed ID: 17122002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of metallo-β-lactamase production and multidrug resistance on clinical outcomes in patients with Pseudomonas aeruginosa bloodstream infection: a retrospective cohort study.
    Willmann M; Kuebart I; Marschal M; Schröppel K; Vogel W; Flesch I; Markert U; Autenrieth IB; Hölzl F; Peter S
    BMC Infect Dis; 2013 Nov; 13():515. PubMed ID: 24176052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metallo-beta-lactamase-producing Pseudomonas aeruginosa isolates in Tunisia.
    Mansour W; Poirel L; Bettaieb D; Bouallegue O; Boujaafar N; Nordmann P
    Diagn Microbiol Infect Dis; 2009 Aug; 64(4):458-61. PubMed ID: 19631102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VIM-2-producing multidrug-resistant Pseudomonas aeruginosa ST175 clone, Spain.
    Viedma E; Juan C; Villa J; Barrado L; Orellana MA; Sanz F; Otero JR; Oliver A; Chaves F
    Emerg Infect Dis; 2012 Aug; 18(8):1235-41. PubMed ID: 22840969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.